Toggle navigation
Home
Search
Services
Blog
Contact
About
Early Therapeutics Development with Phase 2 Emphasis-261017105
Sloan Kettering Institute
Search grants from Sloan Kettering Institute
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Fred Hutchinson Cancer Research Center
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Development and pilot trial of a web-based tool to facilitate shared decision-making with parents of febrile infants
In vitro and in vivo characterization of the cyclic-di-GMP riboswitch
Clinical Relevance of Stress Neuroadaptation in Tobacco Dependence
Nutrition and the Genetics of Prematurity
Trial of Activity for Adolescent Girls - Field Center
Recently added grants:
Strategies and Methods for Complex Molecule Synthesis
Control of spermatogonial stem cell formation
Mechanistic Studies of Type II Topoisomerases and Topoisomerase-Targeted Agents
Computational design of novel protein binders based on structure mining and learning from data
Identifying Predictors of Poor Health-Related Quality-of-life among Pediatric Hematopoietic Stem Cell Donors
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CA017105-005
Application #
6828837
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2003
Total Cost
Indirect Cost
Institution
Name
Sloan Kettering Institute
Department
Type
DUNS #
City
State
Country
Zip Code
Related projects
NIH 2005
N01 CA
Early Therapeutics Development with Phase 2 Emphasis-261017105
/ Sloan Kettering Institute
NIH 2004
N01 CA
Early Therapeutics Development with Phase 2 Emphasis-261017105
/ Sloan Kettering Institute
NIH 2003
N01 CA
Early Therapeutics Development with Phase 2 Emphasis-261017105
/ Sloan Kettering Institute
NIH 2002
N01 CA
Early Therapeutics Development with Phase 2 Emphasis-261017105
/ Sloan Kettering Institute
Comments
Be the first to comment on this grant